These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10906637)

  • 1. Advances in specific immunotherapy of malignant melanoma.
    Curiel-Lewandrowski C; Demierre MF
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):167-85; quiz 186-8. PubMed ID: 10906637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunology and immunotherapy of human malignant melanoma.
    Bystryn JC
    Dermatol Clin; 1985 Apr; 3(2):327-34. PubMed ID: 2937585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy of malignant melanoma--basic principles and novel therapeutic approaches].
    Enk AH; Becker JC; Schuler G
    J Dtsch Dermatol Ges; 2006 Aug; 4(8):635-45. PubMed ID: 16895565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A malignus melanoma immunterápiájának lehetoségei].
    Ladányi A
    Magy Onkol; 2003; 47(1):113-7. PubMed ID: 12704464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of advanced or metastatic melanoma.
    Cebon J; Gedye C; John T; Davis ID
    Clin Adv Hematol Oncol; 2007 Dec; 5(12):994-1006. PubMed ID: 18277962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of immunotherapy in the treatment of melanoma.
    Faries MB
    Surg Oncol Clin N Am; 2006 Apr; 15(2):399-418. PubMed ID: 16632223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for advanced melanoma: fulfilling the promise.
    Gogas H; Polyzos A; Kirkwood J
    Cancer Treat Rev; 2013 Dec; 39(8):879-85. PubMed ID: 23725878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
    Speeckaert R; van Geel N; Vermaelen KV; Lambert J; Van Gele M; Speeckaert MM; Brochez L
    Pigment Cell Melanoma Res; 2011 Apr; 24(2):334-44. PubMed ID: 21029398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration.
    Andersen MH; Gehl J; Reker S; Pedersen LØ; Becker JC; Geertsen P; thor Straten P
    Semin Cancer Biol; 2003 Dec; 13(6):449-59. PubMed ID: 15001164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic strategies for the treatment of malignant melanoma.
    Alexeev V; Mucci T; Igoucheva O
    G Ital Dermatol Venereol; 2008 Apr; 143(2):139-49. PubMed ID: 18833040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Local immunotherapy. Alternative therapy for malignant cutaneous lesions (demonstration on 30 patients with malignant melanoma) (author's transl)].
    Kokoschka EM; Micksche M
    Wien Klin Wochenschr; 1979 Mar; 91(5):150-4. PubMed ID: 425533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for cutaneous malignancy.
    Ibrahim SF; Sambandan D; Ratner D
    Dermatol Surg; 2011 Oct; 37(10):1377-93. PubMed ID: 21806705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of melanoma.
    Parmiani G; Castelli C; Rivoltini L; Casati C; Tully GA; Novellino L; Patuzzo A; Tosi D; Anichini A; Santinami M
    Semin Cancer Biol; 2003 Dec; 13(6):391-400. PubMed ID: 15001157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment.
    Gajewski TF
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5256-61. PubMed ID: 17875753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotherapy of melanoma].
    Dréno B
    Bull Acad Natl Med; 2010 Oct; 194(7):1373-81. PubMed ID: 22043632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy in malignant melanoma].
    Braathen LR; Hunger RE; Brand CU
    Zentralbl Chir; 2000; 125(10):806-9. PubMed ID: 11098573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possibilities of immunotherapy in malignant melanoma].
    Lewis MG
    Hautarzt; 1978 Dec; 29(12):619-24. PubMed ID: 363650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of melanoma with an emphasis on immunotherapeutic strategies.
    Jack A; Boyes C; Aydin N; Alam K; Wallack M
    Surg Oncol; 2006 Jul; 15(1):13-24. PubMed ID: 16815006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma-induced immunosuppression and its neutralization.
    Umansky V; Sevko A
    Semin Cancer Biol; 2012 Aug; 22(4):319-26. PubMed ID: 22349515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
    Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
    Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.